Tag Archives: AADvac1

June, 2016

  • 22 June

    AXON’s Alzheimer’s Vaccine Starts Mid-Stage Trial

    BRATISLAVA, Slovakia–(BUSINESS WIRE)–AXON Neuroscience announced the successful start of the ADAMANT phase II study, as the first patient has been vaccinated with the active tau vaccine. AXON’s vaccine, AADvac1, is intended to be the first disease-modifying tau vaccine for Alzheimer’s disease. ADAMANT PHASE II CLINICAL STUDY ADAMANT is a 24-month, …